Article
EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis.
BMC cancer - 1 Jun 2006
Kokko Antti, Laiho Päivi, Lehtonen Rainer, Korja Sanna, Carvajal-Carmona Luis G, Järvinen Heikki, Mecklin Jukka-Pekka, Eng Charis, Schleutker Johanna, Tomlinson Ian P M, Vahteristo Pia, Aaltonen Lauri A
Abstract excerpt
BACKGROUND: Ephrin receptor B2 (EPHB2) has recently been proposed as a novel tumor suppressor gene in colorectal cancer (CRC). Inactivation of the gene has been shown to correlate with progression of colorectal tumorigenesis, and somatic mutations have been reported in both colorectal and prostate tumors. METHODS: Here we have analyzed the EPHB2 gene for germline alterations in 101 individuals either with 1) CRC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
